EMA starts rolling review for Moderna’s COVID-19 vaccine candidate

Europe’s health regulator said on Monday it had started a real-time review of Moderna Inc’s experimental vaccine for COVID-19, on the back of similar such review launches for vaccines from AstraZeneca and Pfizer .

The European Medicines Agency’s human medicines committee has started a “rolling review” for Moderna’s mRNA-1273 vaccine candidate and has already started evaluating the first batch of data, the regulator said.

Discover more from The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights